Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$114.22 - $140.1 $1.4 Million - $1.72 Million
-12,263 Reduced 70.37%
5,164 $716,000
Q4 2023

Jan 12, 2024

BUY
$75.49 - $124.16 $1.12 Million - $1.85 Million
14,889 Added 586.64%
17,427 $2.16 Million
Q3 2023

Oct 24, 2023

BUY
$86.06 - $137.93 $218,420 - $350,066
2,538 New
2,538 $236,000
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $2,753 - $3,669
34 New
34 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Advisor Resource Council Portfolio

Follow Advisor Resource Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Resource Council with notifications on news.